Janus kinase (JAK) inhibitors are associated with decreased mortality and fewer serious adverse events among adults hospitalized with COVID-19.

COVID-19 cases are rising in 26 states. Is the US in a summer wave? What to know about COVID trends and symptoms of the new ...

Pemivibart was well tolerated and prophylactic against COVID-19 infection among adult patients with significant immunocompromising conditions.

“Some people think that if they got the vaccine or feel healthy, they don’t need treatment,” said Karyne Jones, President and CEO of NCBA, Inc. and co-convener of CVEEP. “But that’s not always true.

Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...

One very influential set of guidelines — viewed more than 50 million times and used by doctors around the world — is the COVID-19 Treatment Guidelines from the National Institutes of Health (NIH).